Main Industry
Health Care
Main Product/Service
1. Ostevoke Bone Graft
2. Porcine Collagen Type I
3. Rat Tail Collagen Type I
4. μCapsul™ Controlled-Release Polymer
5. Formulation Service
2. Porcine Collagen Type I
3. Rat Tail Collagen Type I
4. μCapsul™ Controlled-Release Polymer
5. Formulation Service
The content above was translated by Ai
Founded Year
2022
Unified Business No.
89116193
Status
Active
Number of Employees
0
Total Paid-in
Capital
30,006,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Expercy: A Pioneer in Regenerative Biomaterials
Expercy pioneers "Synchronous Therapeutic Systems" through proprietary "Designing Living Materials" technology — biomaterials that respond in real-time to physiological healing cues. With R&D across Taiwan, Europe, and the USA, we reduce post-surgical complications and costly Return-to-OR events, transforming regenerative medicine for global clinical partners.
Expercy pioneers "Synchronous Therapeutic Systems" through proprietary "Designing Living Materials" technology — biomaterials that respond in real-time to physiological healing cues. With R&D across Taiwan, Europe, and the USA, we reduce post-surgical complications and costly Return-to-OR events, transforming regenerative medicine for global clinical partners.
The content above was translated by Ai
